Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms

Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms

Redirecting CD8 T cell immunity with self/tumor-specific affinity-matured T cell receptors (TCRs) is a promising approach for clinical adoptive T cell therapy, with the aim to improve treatment efficacy. Despite numerous functional-based studies, little is known about the characteristics of TCR sign...

Full description

Bibliographic Details
Main Authors:	Danilo Presotto, Efe Erdes, Minh Ngoc Duong, Mathilde Allard, Pierre-Olivier Regamey, Manfredo Quadroni, Marie-Agnès Doucey, Nathalie Rufer, Michael Hebeisen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-11-01
Series:	Frontiers in Immunology
Subjects:	cancer immunotherapy NY-ESO-1 antigen T cell receptor engineering T cell receptor-peptide-major histocompatibility complex affinity hyporesponsiveness CD3ζ
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.01564/full

Similar Items

Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
by: Minh Ngoc Duong, et al.
Published: (2019-11-01)

CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity
by: Petra Baumgaertner, et al.
Published: (2022-08-01)

TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors
by: Alaa Alsalloum, et al.
Published: (2023-10-01)

Erratum: CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity
by: Frontiers Production Office
Published: (2023-03-01)

The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses
by: Diana Campillo-Davo, et al.
Published: (2020-07-01)

TCR Fingerprinting and Off-Target Peptide Identification
by: Armen R. Karapetyan, et al.
Published: (2019-10-01)

Conformational flexibility of a free and TCR-bound pMHC-I protein investigated by long-term molecular dynamics simulations
by: Lisa Tomasiak, et al.
Published: (2022-07-01)

Genetic and environmental determinants of human TCR repertoire diversity
by: Chirag Krishna, et al.
Published: (2020-09-01)

Reprogramming of IL-12 secretion in the PDCD1 locus improves the anti-tumor activity of NY-ESO-1 TCR-T cells
by: Segi Kim, et al.
Published: (2023-01-01)

Asymmetric framework motion of TCRαβ controls load-dependent peptide discrimination
by: Ana C Chang-Gonzalez, et al.
Published: (2024-01-01)

TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
by: Francesco Manfredi, et al.
Published: (2020-09-01)

Intramolecular Domain Movements of Free and Bound pMHC and TCR Proteins: A Molecular Dynamics Simulation Study
by: Rudolf Karch, et al.
Published: (2019-07-01)

Evolutionary trade-offs constraining the MHC gene expansion: beyond simple TCR depletion model
by: Magdalena Migalska, et al.
Published: (2024-01-01)

CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins
by: Christian Jost, et al.
Published: (2020-01-01)

Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report
by: Maysaloun Merhi, et al.
Published: (2018-07-01)

TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens
by: Yoshiki Akatsuka
Published: (2020-02-01)

Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells
by: Wenjie Gong, et al.
Published: (2021-01-01)

Soluble Expression of Fc-Fused T Cell Receptors Allows Yielding Novel Bispecific T Cell Engagers
by: Wen-Bin Zhao, et al.
Published: (2021-07-01)

Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells
by: Chad M. Williams, et al.
Published: (2017-07-01)

TCR Signaling In T Cell Memory
by: Emma eTeixeiro, et al.
Published: (2015-12-01)

Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
by: Indu Ramachandran, et al.
Published: (2019-10-01)

Generated SecPen_NY-ESO-1_ubiquitin-pulsed dendritic cell cancer vaccine elicits stronger and specific T cell immune responses
by: Yunkai Yang, et al.
Published: (2021-02-01)

Molecular alterations in the TCR signaling pathway in patients with aplastic anemia
by: Bo Li, et al.
Published: (2016-03-01)

NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route
by: Obed Boadi Amissah, et al.
Published: (2024-02-01)

Human TCR repertoire in cancer
by: Lin Chen, et al.
Published: (2024-09-01)

On the control of TCR phosphorylation
by: Ricardo eFernandes, et al.
Published: (2012-05-01)

A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells
by: Junko Matsuzaki, et al.
Published: (2019-01-01)

TCR-T Immunotherapy: The Challenges and Solutions
by: Yating Liu, et al.
Published: (2022-01-01)

TCR engineered T cells for solid tumor immunotherapy
by: Yikai Zhang, et al.
Published: (2022-06-01)

Machine Learning Approaches to TCR Repertoire Analysis
by: Yotaro Katayama, et al.
Published: (2022-07-01)

Domain-swapped T cell receptors improve the safety of TCR gene therapy
by: Michael T Bethune, et al.
Published: (2016-11-01)

Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
by: Jocelyn Joseph, et al.
Published: (2019-11-01)

Artificial T Cell Adaptor Molecule-Transduced TCR-T Cells Demonstrated Improved Proliferation Only When Transduced in a Higher Intensity
by: Toshiyasu Sakai, et al.
Published: (2020-09-01)

Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
by: Paul Shafer, et al.
Published: (2022-03-01)

T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope
by: Mesha Saeed, et al.
Published: (2020-05-01)

Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
by: Jan A. Rath, et al.
Published: (2020-06-01)

A Cysteine Residue within the Kinase Domain of Zap70 Regulates Lck Activity and Proximal TCR Signaling
by: Annika Schultz, et al.
Published: (2022-09-01)

Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
by: Barbara Couturaud, et al.
Published: (2023-11-01)

Targeting cancers through TCR-peptide/MHC interactions
by: Qinghua He, et al.
Published: (2019-12-01)

Biophysical Characterization of CD6—TCR/CD3 Interplay in T Cells
by: Marjolein B. M. Meddens, et al.
Published: (2018-10-01)